Spinal Muscular Atrophy: Current Advances in Treatment and Recommendations for Evaluation and Rehabilitation (RECORDED SESSIONS)

Date & Location

Wednesday, April 1, 2020, 12:00 AM - Friday, March 31, 2023, 12:00 AM

Overview

Internet Enduring Material Sponsored by Stanford University School of Medicine. Presented by the Division of Neuromuscular Medicine at Stanford University School of Medicine.

This online course is provided to first, teach healthcare providers on the clinical perspective of spinal muscular atrophy (SMA) including the broad phenotypic spectrum of pediatric and adult patients, evidence of natural history of the disease, new updates to standards of care, clinical outcome measures/standardized assessments, and the influence of therapies both approved and in development; and second, to support healthcare providers, outside of specialized SMA centers, to manage rehabilitation programs and evaluate patient progress using validated standardized clinical assessments in SMA.

At the end of this course, participants will have an understanding of the current advances in treatment as well as recommendations for the evaluation and rehabilitation management in SMA. Attendees will comprehend how to relate the standards of care to clinical practice and assess SMA patients with standardized clinical measures.

Target Audience
This is an international program designed for physicians, nurses, advance practice nurses (APNs), professional nurses (RNs) physician assistants, physical therapists, administrators, researchers, social workers, allied health professionals, occupational therapists, speech language pathologists, residents, fellows and medical students specializing in Neurology, Pediatrics, and Neuromuscular specialties.

Registration

Release Date: April 1, 2020
Expiration Date: April 1, 2023
Estimated Time to Complete: 13.75 hours
Registration Fee: FREE
*Originally recorded on 12/06/2019 and 12/07/2019.

Want to attend live? Stanford University 2nd Annual Spinal Muscular Atrophy Continuing Medical Education Conference on December 4 – 5, 2020. Learn more HERE.

Credits

AMA PRA Category 1 Credits™ (13.75 hours), Non-Physician Participation Credit (13.75 hours)

Target Audience

Specialties - Neurology , Pediatrics

Professions - Fellow/Resident, Non-Physician, Physician, Student

Objectives

At the conclusion of this activity, participants should be able to:

Summarize the clinical perspectives of sma including disease pathology, phenotypic spectrum, and evidence of natural history.
Choose and organize suitable rehabilitation programs based on available standards of care recommendations.
Determine and apply appropriate clinical outcome measures based on age and function with correct administration and scoring of motor performance using these common sma measures.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 13.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Accessibility Statement
Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, please contact us.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws. You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Reference/Bibliography List
Click HERE to view audience Q&A submitted during the live conference.

John W. Day, MD, PhD	Advisory Board & Contracted Research	Biogen, Roche/ Genentech, AveXis, Novartis, Cytokinetics, Scholar Rock
Basil Darras, MD	Advisory Board	AveXis, Biogen, Cytokinetics, Dynacure, Roche, Genentech, Sarepta
	Speaker’s Bureau	Biogen
	Contracted Research	National Institute of Neurological Disorders and Stroke, the Slaney Family Fund for SMA, Working on Walking Fund, the SMA Foundation; CureSMA, Ionis Pharmaceuticals, Inc. and Biogen during ENDEAR, CHERISH, CS2, CS12, CS11 studies, AveXis, Cytokinetics, Fibrogen, PTC, Roche, Santhera, Sarepta, and Summit.
Sally Dunaway Young, PT, DPT	Advisory Board	Biogen, Scholar Rock
	Consulting Fees	Biogen, Ionis, Scholar Rock, Cure SMA
Tina Duong, MPT	Consulting Fees	Roche, Biogen, Scholar Rock, Cytokinetics, Novartis, Audentes
	Advisory Board	Roche, Biogen, Cytokinetics, Audentes
Richard S. Finkel, MD	Advisory Board & Contracted Research	AveXis, Biogen, Roche
Richard Gee, PT	Advisory Board & Consulting Fees	Biogen Pharmaceutical
Allan M. Glanzman, PT, DPT	Intellectual Property rights	Audentis, Roche, Biogen, AveXis
	Consulting Fees	Audentis, Aspa
Oscar Mayer, MD	Advisory Board & Speaker’s Bureau	Biogen